Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis

Abstract: Secondary acute myeloid leukemia (s-AML) includes therapy-related AML and AML evolving from antecedent hematological disorder (AHD). s-AML arising after treating AHD likely represents a prognostically distinct, high-risk disease category. In this study, treated s-AML (ts-AML) was defined b...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Prajwal Boddu, Hagop M. Kantarjian, Guillermo Garcia-Manero, Farhad Ravandi, Srdan Verstovsek, Elias Jabbour, Gautam Borthakur, Marina Konopleva, Kapil N. Bhalla, Naval Daver, Courtney D. DiNardo, Christopher B. Benton, Koichi Takahashi, Zeev Estrov, Sherry R. Pierce, Michael Andreeff, Jorge E. Cortes, Tapan M. Kadia
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2017-07-01
Serie:	Blood Advances
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2473952920302500
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!